Sector
PharmaceuticalsOpen
₹12.55Prev. Close
₹12.54Turnover(Lac.)
₹170.33Day's High
₹13.24Day's Low
₹12.4852 Week's High
₹24.9152 Week's Low
₹10.3Book Value
₹4.07Face Value
₹2Mkt Cap (₹ Cr.)
137.63P/E
156.75EPS
0.08Divi. Yield
028 Aug 2024
12:00 AM
Split
24 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 10.72 | 10.55 | 10.55 | 10.55 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 32.12 | 29.99 | 15.81 | 11.87 |
Net Worth | 42.84 | 40.54 | 26.36 | 22.42 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Revenue | 53.77 | 60.08 | 75.09 | 67.76 |
yoy growth (%) | -10.5 | -19.98 | 10.81 | 5.92 |
Raw materials | -46.15 | -51.08 | -68.66 | -59.9 |
As % of sales | 85.82 | 85.02 | 91.43 | 88.39 |
Employee costs | -1.84 | -1.93 | -2.12 | -2.03 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 1.4 | 0.07 | 1.13 | 1.34 |
Depreciation | -0.42 | -0.43 | -0.26 | -0.25 |
Tax paid | -0.35 | -0.04 | -0.41 | -0.54 |
Working capital | 2.05 | 0.78 | -1.22 | 11.94 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -10.5 | -19.98 | 10.81 | 5.92 |
Op profit growth | 218.59 | -59.84 | -26.33 | -19.59 |
EBIT growth | 56.8 | -32.1 | -10.16 | 1.6 |
Net profit growth | 3,091.33 | -95.4 | -10.53 | 12.19 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,727.5 | 96.95 | 4,14,533.1 | 2,000.46 | 0.93 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,790 | 81.58 | 1,80,214.67 | 667 | 0.44 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,490.9 | 25.02 | 1,20,427.63 | 1,485.4 | 1.07 | 4,254.47 | 397.39 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,439.6 | 61.52 | 1,16,404.77 | 474 | 0.17 | 2,385 | 224.34 |
Mankind Pharma Ltd MANKIND | 2,651 | 58.1 | 1,09,463.92 | 382.46 | 0 | 2,126.59 | 354.71 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Atul Vasani
Whole-time Director
Jagruti Vasani
Executive Director
Dewansh Vasani
Independent Director
Manish Bhagwandas Ved
Company Sec. & Compli. Officer
Vishwa Mekhia
Independent Director
Pratik Vikram Jakhelia
706 to 709 7th Floor Aravali,
Business Centre Borivali(W),
Maharashtra - 400092
Tel: 91-22-28928833
Website: http://www.vaishalipharma.com
Email: investor@vaishalipharma.com
Office No 56-2,
Pinnacle Busine.Park, Mahakali Caves Road,
Mumbai - 400093
Tel: 91-22-62638200
Website: www.bigshareonline.com
Email: investor@bigshareonline.com
Summary
Vaishali Pharma Limited was originally incorporated as a Private Limited Company with the name Vaishali Pharma Private Limited on 25th, April 2008. On July 01, 2008 the Company acquired the business o...
Read More
Reports by Vaishali Pharma Ltd
What is the Vaishali Pharma Ltd share price today?
What is the Market Cap of Vaishali Pharma Ltd?
What is the PE and PB ratio of Vaishali Pharma Ltd?
What is the 52 Week High and Low of Vaishali Pharma Ltd?
What is the CAGR of Vaishali Pharma Ltd?
What is the shareholding pattern of Vaishali Pharma Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.